secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMARIN CORP PLCUK (AMRN)
CIK:        0000897448
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0000950170-25-099878
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amarin Q2 net loss $14.1M; signs European licensing deal with Recordati, plans restructuring
--------------------------------------------------------------------------------

- Q2 net loss of $14.1M ($0.03 per share) vs. $1.5M net income in Q2 2024.
- Total net revenue $72.7M (+8% YoY); licensing revenue up 31% on Recordati upfront.
- Signed exclusive European licensing agreement with Recordati for VAZKEPA in 59 countries.
- Global restructuring expected to deliver $70M in operating expense savings over 12 months.
- Cash $298.7M, debt-free; U.S. product revenue down 17% to $36.5M, Europe up 85% to $6.6M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/897448/000095017025099878/0000950170-25-099878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/897448/000095017025099878/amrn-20250730.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-099878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer